Can You Take NMN Orally? Or Only Sublingually?

What’s the best, most effective way to take NMN?

Is oral administration effective? Should it be taken sublingually (dissolved under the tongue)? Or is NMN only available via injection?

Some sources suggest that NMN cannot be effectively absorbed when taken orally, while others claim that sublingual administration is necessary and that swallowing a capsule is insufficient.

However, these statements are based on outdated information and do not reflect the current body of evidence.

Orally-taken NMN is absorbed well

Recent evidence indicates that NMN can be effectively administered orally. Sublingual delivery is not required; standard oral intake (e.g., capsules or powders) is sufficient. Available data demonstrate that NMN is absorbed following oral ingestion.

Earlier preclinical studies commonly used intraperitoneal injection of NMN in mice. This led to the assumption that NMN might not be effective when taken orally. However, this interpretation is not supported by more recent findings.

Subsequent studies have shown that when NMN is administered orally, such as through drinking water or diet in animal models, it is readily absorbed, appears in systemic circulation, and increases intracellular NAD⁺ levels. NMN serves as a precursor to NAD⁺, a critical cofactor involved in cellular processes including DNA repair and regulation of inflammation.

In these studies, oral NMN administration has also been associated with improvements in multiple physiological parameters, including vascular function, physical endurance, insulin sensitivity, body weight regulation, immune function, bone density, visual function, and mitochondrial metabolism.(R ,R ,R ,R).

Cellular uptake of NMN

Earlier hypotheses suggested that NMN could not be directly taken up by cells. It was proposed that NMN first needed to be converted extracellularly into nicotinamide riboside (NR), which could then cross the cell membrane and be reconverted into NMN intracellularly.

However, more recent evidence indicates that specific transport mechanisms for NMN exist at the cell membrane, enabling direct cellular uptake. Emerging data also suggest that additional NMN transport pathways may be present, although their role and relevance in humans remain under investigation (R,R).

Gastrointestinal absorption and systemic stability of NMN

An important consideration, beyond cellular uptake, is whether NMN reaches the systemic circulation in a stable form following oral administration.

Available evidence indicates that NMN remains relatively stable in the gastrointestinal tract and is efficiently absorbed. Following absorption, NMN can be detected in the bloodstream, supporting its bioavailability.

Comparative data suggest that nicotinamide riboside (NR) is less stable in the gastrointestinal environment and circulation. NR is largely metabolized to nicotinamide prior to, or shortly after, absorption, including first-pass metabolism in the liver. As a result, increases in NAD⁺ levels following NR supplementation are generally mediated indirectly via nicotinamide.

In contrast, NMN appears to persist in a more intact form for longer periods in both the gastrointestinal tract and circulation, which may facilitate more direct contribution to NAD⁺ biosynthesis. However, the extent to which these differences translate into clinically meaningful outcomes in humans remains an area of ongoing research.

Evidence across species and real-world use of NMN

Preclinical research has investigated NMN supplementation in multiple animal models, including rodents and other mammalian species. These studies consistently show that orally administered NMN can be absorbed through the gastrointestinal tract and is associated with downstream increases in NAD⁺ levels and physiological changes in various tissues. However, the majority of mechanistic and efficacy data remain derived from animal studies, and the strength of evidence varies by species and experimental design.

In humans, pharmacokinetic and clinical data are more limited, but available studies suggest that NMN is orally bioavailable and can influence NAD⁺ metabolism.

NMN has also been used in non-controlled, real-world contexts by researchers and individuals interested in NAD⁺ biology. For example, it has been publicly discussed that some scientists, including Professor David Sinclair, report consuming NMN orally as part of their personal supplementation routines (as described in Lifespan). These anecdotal reports, however, do not constitute clinical evidence.

Overall, current evidence supports the conclusion that NMN can be taken orally and is biologically active. Oral administration appears sufficient for systemic exposure, and there is no established requirement for sublingual delivery or injection based on current human evidence. However, comparative efficacy and long-term clinical outcomes in humans are still under investigation.

Accordingly, NMN is generally considered suitable for oral use in supplement form, without the need for more invasive or specialized administration routes.

Learn more about the anti-aging supplement NOVOS Boost, containing high-quality, high-purity NMN

These statements have not been evaluated by the Food and Drug Administration. This product/information is not intended to diagnose, treat, cure, or prevent any disease.